Showing results (411-420 of 435) with videos related to

Sort By:
Pageof 44
International Journal of Cancer|July 1, 2023
Panitumumab plus trifluridine/tipiracil as anti-EGFR rechallenge therapy in patients with refractory RAS wild-type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trialStefania Napolitano, Davide Ciardiello, Vincenzo De Falco, et al.
Cellular and Molecular Life Sciences : CMLS|July 13, 2022
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiencyAlbino Carrizzo, Concetta Iside, Angela Nebbioso, et al.
Bioorganic Chemistry|October 18, 2025
New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cellsIlaria Cursaro, Luca Frattaruolo, Laura Scalvini, et al.
JAMA Oncology|May 18, 2023
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical TrialStefania Napolitano, Vincenzo De Falco, Giulia Martini, et al.
The International Journal of Biochemistry & Cell Biology|July 3, 2007
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activitiesPaola Bontempo, Luigi Mita, Marco Miceli, et al.
ESMO Open|April 3, 2020
Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania 'Luigi Vanvitelli'Vincenzo De Falco, Luca Poliero, Pietro Paolo Vitello, et al.
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|April 21, 2020
Molecular networks in Network Medicine: Development and applicationsEdwin K Silverman, Harald H H W Schmidt, Eleni Anastasiadou, et al.
Cell Reports|November 17, 2016
The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLsAmit Mandoli, Abhishek A Singh, Koen H M Prange, et al.
Cancers|November 13, 2025
Genetic, Epidemiological, Clinical, and Therapeutic Trajectories in Colon and Rectal CancersMaurizio Capuozzo, Carmine Picone, Francesco Sabbatino, et al.
Oncogene|September 13, 2025
METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axisGuglielmo Bove, Mehrad Babaei, Alberto Bueno-Costa, et al.
Pageof 44